Radiotherapy in Lung Cancer: Current and Future Role

Esengül Koçak Uzel; Metin Figen; Ömer Uzel

doi:10.14744/SEMB.2019.25991

Radiotherapy in Lung Cancer: Current and Future Role

Sisli Etfal Hastan Tip Bul. 2019 Nov 21;53(4):353-360. doi: 10.14744/SEMB.2019.25991. eCollection 2019.

Authors

Esengül Koçak Uzel¹, Metin Figen¹, Ömer Uzel²

Affiliations

¹ Department of Radiation Oncology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
² Department of Radiation Oncology, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey.

Abstract

Lung cancer is divided into two subgroups concerning its natural course and treatment strategies as follows: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). In this review, for NSCLC, the role of stereotactic body radiation therapy (SBRT) in early-stage, chemoradiation in the locally advanced stage, post-operative radiotherapy for patients with high risk after surgery and radiotherapy for metastatic disease will be discussed. Also, for SCLC, the role and timing of thoracic irradiation and prophylactic cranial irradiation (PCI) for the limited and extensive stages will be discussed.

Keywords: Lung Cancer; Non-small cell lung cancer (NSCLC); Small cell lung cancer (SCLC); prophylactic cranial irradiation (PCI); stereotactic body radiation therapy (SBRT).

Publication types

Review